These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21114540)

  • 41. Management of central giant cell granuloma of mandible using intralesional corticosteroids: case report and review of literature.
    Ferretti C; Muthray E
    J Oral Maxillofac Surg; 2011 Nov; 69(11):2824-9. PubMed ID: 21292370
    [No Abstract]   [Full Text] [Related]  

  • 42. Topical tretinoin as an adjunctive therapy with intralesional triamcinolone acetonide for alopecia areata. Clinical experience in northern Saudi Arabia.
    Kubeyinje EP; C'Mathur M
    Int J Dermatol; 1997 Apr; 36(4):320. PubMed ID: 9169343
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of severe alopecia areata with intralesional steroid injections.
    Chang KH; Rojhirunsakool S; Goldberg LJ
    J Drugs Dermatol; 2009 Oct; 8(10):909-12. PubMed ID: 19852119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resolution of foveal pseudocyst after intravitreal triamcinolone acetonide.
    Ozdemir H; Karacorlu M; Karacorlu S
    Acta Ophthalmol Scand; 2005 Oct; 83(5):619-20. PubMed ID: 16188005
    [No Abstract]   [Full Text] [Related]  

  • 45. Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.
    Prabhasawat P; Tesavibul N; Leelapatranura K; Phonjan T
    Ophthalmology; 2006 Jul; 113(7):1102-9. PubMed ID: 16730066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [An experimental study on the mechanism of therapy for hemangioma with glucocorticoid].
    Yu S; Liu WY; Tang YM; Wei T
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1121-4. PubMed ID: 16029572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal triamcinolone acetonide for exudative age related macular degeneration.
    Wong D; Campbell I; Groenwald C; Lancaster E
    Br J Ophthalmol; 2004 Apr; 88(4):598; author reply 598. PubMed ID: 15031200
    [No Abstract]   [Full Text] [Related]  

  • 48. Subconjunctival triamcinolone acetonide injection in the treatment of acute noninfectious nonnecrotizing anterior scleritis.
    Onal S; Asfuroglu E; Kazokoglu H
    Am J Ophthalmol; 2010 Jun; 149(6):1012; author reply 1012-3. PubMed ID: 20510689
    [No Abstract]   [Full Text] [Related]  

  • 49. A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection.
    Hernaez-Ortega MC; Soto-Pedre E
    Ophthalmic Surg Lasers Imaging; 2004; 35(4):350-1. PubMed ID: 15305565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pilot study on the role of intralesional triamcinolone acetonide in the treatment of pitted nails in children.
    Khoo BP; Giam YC
    Singapore Med J; 2000 Feb; 41(2):66-8. PubMed ID: 11063205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Guess What! Follicular mucinosis.
    Amichai B; Grunwald MH
    Eur J Dermatol; 1998; 8(7):525-6. PubMed ID: 9917176
    [No Abstract]   [Full Text] [Related]  

  • 53. Safety of intravitreal high-dose reinjections of triamcinolone acetonide.
    Jonas JB; Degenring R; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Dec; 138(6):1054-5. PubMed ID: 15629306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intralesional corticosteroid injection for central giant cell granuloma: an alternative treatment for children.
    Wendt FP; Torriani MA; Gomes AP; de Araujo LM; Torriani DD
    J Dent Child (Chic); 2009; 76(3):229-32. PubMed ID: 19941766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paracentesis before or after intravitreal injection of triamcinolone acetonide and its necessity?
    Lin JM; Tsai YY; Chiu YT; Hung PT
    Am J Ophthalmol; 2006 May; 141(5):985-6; author reply 986. PubMed ID: 16678539
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral Crohn's disease: a favorable clinical response with delayed-release triamcinolone acetonide intralesional injections.
    Mignogna MD; Fortuna G; Leuci S; Amato M
    Am J Gastroenterol; 2008 Nov; 103(11):2954-5. PubMed ID: 19032484
    [No Abstract]   [Full Text] [Related]  

  • 58. Intralesional corticosteroid injection for treatment of idiopathic subglottic stenosis.
    Delgado-Vargas B; Sanz López L; Acle Cervera L; Mata Castro N
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(4):256-259. PubMed ID: 31926599
    [No Abstract]   [Full Text] [Related]  

  • 59. Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis.
    Aggio FB; Muccioli C; Belfort R
    Eye (Lond); 2006 Sep; 20(9):1080-2. PubMed ID: 16200054
    [No Abstract]   [Full Text] [Related]  

  • 60. Repeated intravitreal triamcinolone acetonide for chronic sympathetic ophthalmia.
    Jonas JB; Spandau UH
    Acta Ophthalmol Scand; 2006 Jun; 84(3):436. PubMed ID: 16704716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.